cjc-1295 ipamorelin gh release + | Peptide Therapy CJC-1295/Ipamorelin Benefits, Side Effects, and
Description
10.1038/embor.2011.43 6 D'AppoloniaB
10.1021/cr200084z 44
It must be injected subcutaneously or intramuscularly for bioavailability
For longer-term storage, aliquoting and freezing at 20C or below is preferred to limit freeze-thaw degradation
1 and remained there for 14 consecutive weeks
